Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Real-world Data on Incidence, Clinical Characteristics and Outcome of Patients with Macrofocal Multiple Myeloma (MFMM) in the Era of Novel Therapies: A study of the Greco-Israeli Collaborative Myeloma Working Group.

Katodritou E, Kastritis E, Gatt M, Cohen YC, Avivi I, Pouli A, Lalayianni A, Lavi N, Delimpasis S, Kyrtsonis MC, Michael M, Suriu C, Miri Z, Tzafarti K, Vadikoliou C, Maltezas D, Zikos P, Ganzel C, Vaxman Y, Aviv A, Christoforidou A, Gavriatopoulou M, Shaulov A, Verrou E, Papanota AM, Fakinos G, Gkioka AI, Palaska V, Triantafyllou T, Konstantinidou P, Anagnostopoulos A, Terpos E, Dimopoulos MA.

Am J Hematol. 2020 Feb 12. doi: 10.1002/ajh.25755. [Epub ahead of print]

PMID:
32048329
2.

The Effect of Sudden Death Bereavement on the Risk for Suicide.

Hamdan S, Berkman N, Lavi N, Levy S, Brent D.

Crisis. 2019 Dec 20:1-11. doi: 10.1027/0227-5910/a000635. [Epub ahead of print]

PMID:
31859558
3.

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.

Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.

Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.

4.

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.

Sant'Antonio E, Guglielmelli P, Pieri L, Primignani M, Randi ML, Santarossa C, Rumi E, Cervantes F, Delaini F, Carobbio A, Betti S, Rossi E, Lavi N, Harrison CN, Curto-Garcia N, Gisslinger H, Gisslinger B, Specchia G, Ricco A, Vianelli N, Polverelli N, Koren-Michowitz M, Ruggeri M, Girodon F, Ellis M, Iurlo A, Mannelli F, Mannelli L, Sordi B, Loscocco GG, Cazzola M, De Stefano V, Barbui T, Tefferi A, Vannucchi AM.

Am J Hematol. 2020 Feb;95(2):156-166. doi: 10.1002/ajh.25677. Epub 2019 Nov 29.

PMID:
31721282
5.

Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.

Ofran Y, Hayun M, Leiba R, Zuckerman T, Horowitz N, Hoffman R, Ringelstein S, Lavi N, Frisch A, Henig I, Gatt ME, Hellmann I, Arad A, Bulvik S, Ram R, Gino-Moor S, Saban R, Tvito A, Rowe JM, Ganzel C.

Am J Hematol. 2020 Jan;95(1):E3-E5. doi: 10.1002/ajh.25651. Epub 2019 Oct 17. No abstract available.

PMID:
31591736
6.

Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up.

Benyamini N, Lavi N, Zuckerman T, Aviv A, Rowe JM, Katz T.

Bone Marrow Transplant. 2019 Sep 16. doi: 10.1038/s41409-019-0671-5. [Epub ahead of print] No abstract available.

PMID:
31527816
7.

Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy.

Beyar-Katz O, Magidey K, Reiner-Benaim A, Barak N, Avivi I, Cohen Y, Timaner M, Avraham S, Hayun M, Lavi N, Bersudsky M, Voronov E, Apte RN, Shaked Y.

Mol Cancer Res. 2019 Nov;17(11):2331-2340. doi: 10.1158/1541-7786.MCR-19-0487. Epub 2019 Aug 13.

PMID:
31409628
8.

Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.

Perry C, Ben Barouch S, Goldschmidt N, Sarid N, Herishanu Y, Shvidel L, Bairey O, Lavi N, Horowitz N, Avigdor A, Lebel E, Sofer O, Ram R, Avivi I.

Am J Hematol. 2019 Sep;94(9):992-1001. doi: 10.1002/ajh.25558. Epub 2019 Jun 18.

PMID:
31211434
9.

Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation.

Beyar-Katz O, Lavi N, Ringelstein-Harlev S, Henig I, Yehudai-Ofir D, Haddad N, Fineman R, Ofran Y, Nov Y, Sahar D, Moustafa-Hawash N, Rowe JM, Zuckerman T.

Leuk Lymphoma. 2019 Oct;60(10):2449-2456. doi: 10.1080/10428194.2019.1594214. Epub 2019 Apr 3.

PMID:
30943060
10.

Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms.

Barzilai M, Kirgner I, Avivi I, Ellis M, Dally N, Rozovski U, Lavi N.

Eur J Haematol. 2019 Jun;102(6):504-508. doi: 10.1111/ejh.13232. Epub 2019 Apr 25.

PMID:
30941804
11.

Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study.

Bitterman R, Hardak E, Raines M, Stern A, Zuckerman T, Ofran Y, Lavi N, Guralnik L, Frisch A, Nudelman O, Paul M, Oren I.

Clin Infect Dis. 2019 Oct 30;69(10):1805-1808. doi: 10.1093/cid/ciz194.

PMID:
30855077
12.

Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma.

Lavi N, Okasha D, Sabo E, Oren I, Benyamini N, Bar-Yoseph H.

Eur J Haematol. 2018 Aug 18. doi: 10.1111/ejh.13164. [Epub ahead of print]

PMID:
30120798
13.

Semaphorin-3A inhibits multiple myeloma progression in a mouse model.

Lavi N, Kessler O, Ziv K, Nir-Zvi I, Mumblat Y, Eiza N, Paran Y, Brenner B, Vadasz Z, Neufeld G.

Carcinogenesis. 2018 Oct 8;39(10):1283-1291. doi: 10.1093/carcin/bgy106.

PMID:
30102336
14.

Decreased amplitude of surface electromyo- graphic recordings of muscle activation along the posterior myofascial kinematic chain in subjects with chronic nonspecific low back pain compared to healthy subjects.

Vulfsons S, Chervonenko S, Haddad M, Weisman MH, Lavi N, Dar G.

J Back Musculoskelet Rehabil. 2018;31(4):785-793. doi: 10.3233/BMR-160627.

PMID:
29865025
15.

Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.

Cohen YC, Saranga A, Gatt ME, Lavi N, Ganzel C, Magen H, Avivi I, Tadmor T, Suriu C, Jarchowsky Dolberg O, Papushado A, Trestman S, Ram R.

Am J Hematol. 2018 Jun;93(6):810-815. doi: 10.1002/ajh.25098. Epub 2018 Apr 28.

16.

Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma.

Lavi N, Avivi I, Kra-Oz Z, Oren I, Hardak E.

Support Care Cancer. 2018 Jul;26(7):2425-2431. doi: 10.1007/s00520-018-4079-3. Epub 2018 Feb 9.

PMID:
29427192
17.

How Do Hunter-Gatherer Children Learn Subsistence Skills? : A Meta-Ethnographic Review.

Lew-Levy S, Reckin R, Lavi N, Cristóbal-Azkarate J, Ellis-Davies K.

Hum Nat. 2017 Dec;28(4):367-394. doi: 10.1007/s12110-017-9302-2. Review.

18.

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey.

Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN.

Leuk Res. 2017 Oct;61:6-9. doi: 10.1016/j.leukres.2017.08.002. Epub 2017 Aug 10.

PMID:
28843161
19.

Allogeneic stem-cell transplantation for myelofibrosis.

Lavi N, Rowe JM, Zuckerman T.

Curr Opin Hematol. 2017 Nov;24(6):475-480. doi: 10.1097/MOH.0000000000000381. Review.

PMID:
28832353
20.

Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.

Lavi N, Shapira G, Zilberlicht A, Benyamini N, Farbstein D, Dann EJ, Bar-Shalom R, Avivi I.

Isr Med Assoc J. 2016 Jul;18(7):411-417.

21.

Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone.

Benyamini N, Avivi I, Dann EJ, Zuckerman T, Lavi N, Katz T.

Ann Hematol. 2017 Mar;96(3):461-467. doi: 10.1007/s00277-016-2897-2. Epub 2016 Dec 24.

PMID:
28013359
22.

Site Formation Processes and Hunter-Gatherers Use of Space in a Tropical Environment: A Geo-Ethnoarchaeological Approach from South India.

Friesem DE, Lavi N, Madella M, Ajithprasad P, French C.

PLoS One. 2016 Oct 26;11(10):e0164185. doi: 10.1371/journal.pone.0164185. eCollection 2016.

23.

Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey.

Koren-Michowitz M, Lavi N, Ellis MH, Vannucchi AM, Mesa R, Harrison CN.

Ann Hematol. 2017 Jan;96(1):87-92. doi: 10.1007/s00277-016-2826-4. Epub 2016 Oct 13.

PMID:
27734130
24.

Myeloproliferative neoplasms in pregnancy: ways to go.

Lavi N, Brenner B.

Br J Haematol. 2016 Oct;175(1):7-9. doi: 10.1111/bjh.14290. Epub 2016 Sep 7. No abstract available.

PMID:
27601254
25.

Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks.

Horowitz NA, Lavi N, Nadir Y, Brenner B.

Thromb Haemost. 2016 Sep 27;116(4):613-7. doi: 10.1160/TH16-02-0099. Epub 2016 Jul 28.

PMID:
27465578
26.

Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.

Hardak E, Avivi I, Berkun L, Raz-Pasteur A, Lavi N, Geffen Y, Yigla M, Oren I.

Infection. 2016 Aug;44(4):491-7. doi: 10.1007/s15010-016-0873-3. Epub 2016 Jan 20.

PMID:
26792011
27.

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.

Muchtar E, Gatt ME, Rouvio O, Ganzel C, Chubar E, Suriu C, Tadmor T, Shevetz O, Lavi N, Shochat T, Cohen YC, Avivi I, Raanani P, Magen H.

Br J Haematol. 2016 Jan;172(1):89-96. doi: 10.1111/bjh.13799. Epub 2015 Nov 16.

PMID:
26567759
28.

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.

Ofran Y, Leiba R, Ganzel C, Saban R, Gatt M, Ram R, Arad A, Bulvik S, Hellmann I, Gino-Moor S, Zuckerman T, Hoffman R, Horowitz N, Lavi N, Ringelstein S, Henig I, Hayun M, Rowe JM.

Am J Hematol. 2015 Dec;90(12):1159-64. doi: 10.1002/ajh.24207. Epub 2015 Nov 17.

29.

Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice.

Ellis MH, Lavi N, Mishchenko E, Dally N, Lavie D, Courevitch A, Gutwein O, Bulvik S, Braester A, Chubar E, Tavor S, Duek A, Kirgner I, Koren-Michowitz M.

Leuk Res. 2015 Aug 12. pii: S0145-2126(15)30356-8. doi: 10.1016/j.leukres.2015.08.003. [Epub ahead of print]

PMID:
26364797
30.

Pemphigoid Gestationis: A Case Report and Review of Management.

Seidel R, Lavi N, Chipps L.

J Drugs Dermatol. 2015 Aug;14(8):904-7. Review.

PMID:
26267738
31.

Author response: Precise staging of lymphoma duringpregnancy using MRI is not always crucial.

Lavi N, Horowitz NA, Brenner B.

Womens Health (Lond). 2015 Mar;11(2):103-4. doi: 10.2217/whe.14.76. No abstract available.

PMID:
25776283
32.

Calreticulin mutations in myeloproliferative neoplasms.

Lavi N.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0035. doi: 10.5041/RMMJ.10169. eCollection 2014 Oct.

33.

Surface electromyographic recordings after passive and active motion along the posterior myofascial kinematic chain in healthy male subjects.

Weisman MH, Haddad M, Lavi N, Vulfsons S.

J Bodyw Mov Ther. 2014 Jul;18(3):452-61. doi: 10.1016/j.jbmt.2013.12.007. Epub 2013 Dec 24.

PMID:
25042322
34.

An update on the management of hematologic malignancies in pregnancy.

Lavi N, Horowitz NA, Brenner B.

Womens Health (Lond). 2014 May;10(3):255-66. doi: 10.2217/whe.14.17. Review.

PMID:
24956292
35.

Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey.

Ellis MH, Lavi N, Vannucchi A, Harrison C.

Thromb Res. 2014 Aug;134(2):251-4. doi: 10.1016/j.thromres.2014.04.032. Epub 2014 May 9.

PMID:
24842684
36.

Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.

Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, Raz-Pasteur A, Lavi N, Saad E, Henig I, Horowitz N, Avivi I, Benyamini N, Fineman R, Ofran Y, Haddad N, Rowe JM, Zuckerman T.

Am J Infect Control. 2013 Dec;41(12):1167-72. doi: 10.1016/j.ajic.2013.04.018.

PMID:
24274912
37.

Group G streptococcal endocarditis-associated hemophagocytic syndrome.

Naffaa M, Awad J, Oren I, Braun E, Lavi N.

Int J Infect Dis. 2013 Dec;17(12):e1237-9. doi: 10.1016/j.ijid.2013.05.004. Epub 2013 Jun 28.

38.

Can scintillation detectors with low spectral resolution accurately determine radionuclides content of building materials?

Kovler K, Prilutskiy Z, Antropov S, Antropova N, Bozhko V, Alfassi ZB, Lavi N.

Appl Radiat Isot. 2013 Jul;77:76-83. doi: 10.1016/j.apradiso.2013.02.022. Epub 2013 Mar 14.

PMID:
23542118
39.

Management of pregnant women with myeloproliferative neoplasms.

Lavi N, Brenner B, Avivi I.

Thromb Res. 2013 Jan;131 Suppl 1:S11-3. doi: 10.1016/S0049-3848(13)70011-2.

PMID:
23452731
40.

New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib.

Horowitz N, Oren I, Lavi N, Zuckerman T, Benyamini N, Kra-Oz Z, Held V, Avivi I.

Bone Marrow Res. 2012;2012:409765. doi: 10.1155/2012/409765. Epub 2012 Nov 29.

41.

Layered activation of epicardial scar in arrhythmogenic right ventricular dysplasia: possible substrate for confined epicardial circuits.

Haqqani HM, Tschabrunn CM, Betensky BP, Lavi N, Tzou WS, Zado ES, Marchlinski FE.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):796-803. doi: 10.1161/CIRCEP.111.967935. Epub 2012 May 25.

PMID:
22634228
42.

Measurement of radon diffusion length in thin membranes.

Malki A, Lavi N, Moinester M, Nassar H, Neeman E, Piasetzky E, Steiner V.

Radiat Prot Dosimetry. 2012 Jul;150(4):434-40. doi: 10.1093/rpd/ncr421. Epub 2012 Jan 9. Erratum in: Radiat Prot Dosimetry. 2014 Dec;162(3):427.

PMID:
22232779
43.

Allergic reaction to suture material after an ICD procedure: device infection mimicry.

Tschabrunn CM, Rosenbach M, Lavi N, Cooper JM.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):330-2. doi: 10.1111/j.1540-8167.2011.02224.x. Epub 2011 Nov 14.

PMID:
22081990
44.

Mechanism of complex fractionated electrograms recorded during atrial fibrillation in a canine model.

Gerstenfeld EP, Lavi N, Bazan V, Gojraty S, Kim SJ, Michele J.

Pacing Clin Electrophysiol. 2011 Jul;34(7):844-57. doi: 10.1111/j.1540-8159.2011.03071.x. Epub 2011 Mar 21.

PMID:
21418250
45.

Temporary external implantable cardioverter defibrillator in the pacemaker-dependent ventricular tachycardia patient.

Cooper JM, Lavi N, Polin GM, Dixit S, Verdino RJ.

Europace. 2011 May;13(5):761-3. doi: 10.1093/europace/euq412. Epub 2010 Nov 24. No abstract available.

PMID:
21106578
46.

Noncontact electroanatomic mapping to characterize typical atrial flutter: participation of right atrial posterior wall in the reentrant circuit.

Dixit S, Lavi N, Robinson M, Riley MP, Callans DJ, Marchlinski FE, Lin D.

J Cardiovasc Electrophysiol. 2011 Apr;22(4):422-30. doi: 10.1111/j.1540-8167.2010.01917.x. Epub 2010 Oct 11.

PMID:
20958830
47.

High-density biatrial pacing protects against atrial fibrillation by synchronizing left atrial tissue.

Hansen JC, Latchamsetty R, Lavi N, Uppuluri S, Lafontaine D, Hastings R, Avitall B.

J Interv Card Electrophysiol. 2010 Mar;27(2):81-7. doi: 10.1007/s10840-009-9453-0. Epub 2009 Dec 9.

PMID:
19997986
48.

Dominant frequency mapping of atrial fibrillation: comparison of contact and noncontact approaches.

Gojraty S, Lavi N, Valles E, Kim SJ, Michele J, Gerstenfeld EP.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):997-1004. doi: 10.1111/j.1540-8167.2009.01488.x.

PMID:
19470038
49.

Characterization of the intense pigment tomato genotype emphasizing targeted fruit metabolites and chloroplast biogenesis.

Lavi N, Tadmor Y, Meir A, Bechar A, Oren-Shamir M, Ovadia R, Reuveni M, Nahon S, Shlomo H, Chen L, Levin I.

J Agric Food Chem. 2009 Jun 10;57(11):4818-26. doi: 10.1021/jf900190r.

PMID:
19391624
50.

Biological and molecular characterization of a new cucurbit-infecting tobamovirus.

Antignus Y, Wang Y, Pearlsman M, Lachman O, Lavi N, Gal-On A.

Phytopathology. 2001 Jun;91(6):565-71. doi: 10.1094/PHYTO.2001.91.6.565.

Supplemental Content

Support Center